These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 20177401)
1. Recent advances in renal phosphate handling. Farrow EG; White KE Nat Rev Nephrol; 2010 Apr; 6(4):207-17. PubMed ID: 20177401 [TBL] [Abstract][Full Text] [Related]
2. Osteo-renal cross-talk and phosphate metabolism by the FGF23-Klotho system. Ohnishi M; Razzaque MS Contrib Nephrol; 2013; 180():1-13. PubMed ID: 23652546 [TBL] [Abstract][Full Text] [Related]
3. The Causes of Hypo- and Hyperphosphatemia in Humans. Koumakis E; Cormier C; Roux C; Briot K Calcif Tissue Int; 2021 Jan; 108(1):41-73. PubMed ID: 32285168 [TBL] [Abstract][Full Text] [Related]
4. [FGF-23: just a phosphate metabolism regulator or something else?]. Sánchez-González MC; Salanova L; Ruano P Reumatol Clin; 2011 Sep; 7 Suppl 2():S5-7. PubMed ID: 21924212 [TBL] [Abstract][Full Text] [Related]
5. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Liu S; Gupta A; Quarles LD Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275 [TBL] [Abstract][Full Text] [Related]
6. [Fibroblast Growth Factor 23-Klotho: a new axis of phosphate balance control]. Prié D; Ureña Torres P; Friedlander G Med Sci (Paris); 2009 May; 25(5):489-95. PubMed ID: 19480830 [TBL] [Abstract][Full Text] [Related]
7. Renal Dnase1 expression is regulated by FGF23 but loss of Dnase1 does not alter renal phosphate handling. Egli-Spichtig D; Zhang MYH; Li A; Pastor Arroyo EM; Hernando N; Wagner CA; Chang W; Perwad F Sci Rep; 2021 Mar; 11(1):6175. PubMed ID: 33731726 [TBL] [Abstract][Full Text] [Related]
8. [Disorders of phosphate metabolism]. Fukumoto S Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440 [TBL] [Abstract][Full Text] [Related]
9. A Practical Clinical Approach to Paediatric Phosphate Disorders. Imel EA; Carpenter TO Endocr Dev; 2015; 28():134-161. PubMed ID: 26138840 [TBL] [Abstract][Full Text] [Related]
10. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. Nakatani T; Ohnishi M; Razzaque MS FASEB J; 2009 Nov; 23(11):3702-11. PubMed ID: 19584304 [TBL] [Abstract][Full Text] [Related]
11. [Endocrine control of serum phosphate: from the discoveries of phosphatonins to novel therapies]. Linglart A; Chaussain C Ann Endocrinol (Paris); 2016 Oct; 77 Suppl 1():S36-S42. PubMed ID: 28645356 [TBL] [Abstract][Full Text] [Related]
12. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Stubbs J; Liu S; Quarles LD Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D and type II sodium-dependent phosphate cotransporters. Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552 [TBL] [Abstract][Full Text] [Related]
14. [Renal hypophosphatemia:pathophysiology and treatment]. Sekine T Clin Calcium; 2016 Feb; 26(2):284-94. PubMed ID: 26813509 [TBL] [Abstract][Full Text] [Related]
15. Renal phosphate handling in human--what can we learn from hereditary hypophosphataemias? Amatschek S; Haller M; Oberbauer R Eur J Clin Invest; 2010 Jun; 40(6):552-60. PubMed ID: 20412291 [TBL] [Abstract][Full Text] [Related]